U.S. Markets closed

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
70.43+0.09 (+0.13%)
At close: 3:59PM EDT

70.62 +0.19 (0.27%)
After hours: 4:13PM EDT

People also watch
Full screen
Previous Close70.34
Bid70.40 x 13300
Ask70.41 x 5400
Day's Range70.11 - 70.75
52 Week Range55.06 - 75.04
Avg. Volume5,390,228
Market Cap112.09B
PE Ratio (TTM)18.26
EPS (TTM)3.86
Earnings DateOct 26, 2017 - Oct 30, 2017
Dividend & Yield2.56 (3.61%)
Ex-Dividend Date2017-07-12
1y Target Est75.56
Trade prices are not sourced from all markets
  • Market Realist7 hours ago

    What Does AbbVie’s Dividend Curve Look Like?

    AbbVie (ABBV) recorded a 12.0% rise in net revenue for 2016, mainly driven by Humira and Imbruvica.

  • 3 Dividend Healthcare Stocks
    Motley Fool8 hours ago

    3 Dividend Healthcare Stocks

    On the hunt for income? Here's why our team of healthcare experts thinks you should check out AbbVie, Medtronic, and ResMed.

  • Capital Cube2 days ago

    AbbVie, Inc. – Value Analysis (NYSE:ABBV) : August 14, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives AbbVie, Inc. a score of 84. Our analysis is based on comparing AbbVie, Inc. with the following peers – Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Biogen Inc., GlaxoSmithKline plc Sponsored ADR, Astrazeneca PLC Sponsored ADR and Neurocrine Biosciences, Inc. ... Read more (Read more...)